Analysis of
Flavonoid and Terpene Lactone Contents in European Ginkgo Dietary Supplements Once
Again Reveals Quality Issues and Adulteration
Reviewed: Czigle S, Tóth J,
Jedlinszki N, Háznagy-Radnai E, Csupor D, Tekelová D. Ginkgo biloba food supplements on
the European market – Adulteration patterns by quality control of selected
samples. Planta Med. 2018;84(6-7):475-482. doi: 10.1055/a-0581-5203.Keywords: Adulteration, flavonoids, Ginkgo biloba, HPLC-MS/MS,
HPLC-UV/Vis, quality control, terpene lactones
In
one of the largest investigations into the quality of ginkgo (Ginkgo biloba, Ginkgoaceae) dietary supplements to date, more
than 50 commercial ginkgo product samples from markets in Europe were analyzed
for their contents of flavonol aglycones (after hydrolysis) and terpene
lactones. Approximately 80% of the analyzed samples were found to have quality
issues. These quality issues were illustrated by the authors using a subset of
11 samples labeled to contain ginkgo leaf extract (n = 8) or powdered ginkgo
leaf (n = 3).
Flavonol aglycones were
quantified in ginkgo extract using high-performance liquid chromatography with
ultraviolet/visible detection (HPLC-UV/Vis), before and after hydrolysis, while
terpene lactones were measured by HPLC with tandem mass spectrometric detection. Based on the analytical data, a number of deviations
from authentic ginkgo were observed. Three ginkgo extracts contained negligible
amounts of terpene lactones (0.03–0.85%), and one sample of powdered leaf did
not contain measurable quantities of these lactones. Four extracts contained
unusually high concentrations of flavonol aglycones (expected to be less than
0.1%) prior to hydrolysis, with up to 3.34% quercetin, 2.11% kaempferol, and
0.79% isorhamnetin. One dietary supplement labeled to contain ginkgo extract
was made with powdered leaf, and one powdered ginkgo leaf product was found to
contain substantial amounts of an unidentified plant material after microscopic
analysis. Overall, two products were found to be of high quality, two products
contained only trace amounts of ginkgo extract, one product marketed as ginkgo
extract contained powdered ginkgo leaf, and the remaining six were deemed to be
adulterated.
Comment: While the approach using specifications listed in the European Pharmacopoeia1 without actually using
pharmacopeial test methods to measure them may be questioned, the paper
provides more evidence of widespread quality issues with ginkgo dietary
supplements. While the addition of flavonol aglycones from extraneous sources
has been the subject of many papers focusing on ginkgo authenticity,2
the sale of ginkgo extracts without appreciable amounts of flavonoids and
diterpenes (i.e., one extract containing only 0.49% flavonoids and 0.03%
terpene lactones respectively, compared to the 24% flavonoids and 6% terpene
lactones found in most standardized extracts) or the sale of powdered leaf as
leaf extract has rarely been documented before. It is up to the industry
members who either sell ginkgo extract or who purchase it to use in finished
consumer products to ensure that future investigations into ginkgo dietary
supplements will show a much improved picture of the quality and authenticity.
References
- Ginkgo
leaf. European Pharmacopoeia 9. Strasbourg, France: Council of Europe;2017: 01/2011:1828.
- Gafner S. Adulteration
of Ginkgo biloba leaf extract. Austin, TX: ABC-AHP-NCNPR Botanical Adulterants Prevention
Program. 2017;1-8.